Igny, France

Benoît Crousse

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Pierre Fabre Medicament, Université Paris-Sud 11. Active years: 2008-2013.


 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Verrieres le Buisson, FR (2008 - 2010)
  • Igny, FR (2012 - 2013)

Company Filing History:


Years Active: 2008-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Benoît Crousse: Innovator in Anti-Cancer Therapy

Introduction

Benoît Crousse is a notable inventor based in Igny, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer therapies. With a total of four patents to his name, Crousse's work is recognized for its innovative approach to treating cancer.

Latest Patents

Crousse's latest patents include dimeric derivatives of artemisinin and their application in anti-cancer therapy. The first patent describes dimeric derivatives of 10-trifluoromethylated artemisinin, along with their pharmaceutically acceptable salts. This invention outlines the preparation methods and various uses of these derivatives, especially in cancer treatment. The second patent also focuses on dimeric derivatives of artemisinin, detailing their use in treating cancer and the methods of preparation.

Career Highlights

Throughout his career, Benoît Crousse has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Pierre Fabre Medicament. His experience in these institutions has allowed him to advance his research and contribute to significant developments in the pharmaceutical industry.

Collaborations

Crousse has collaborated with notable colleagues, including Jean-Pierre Begue and Danièle Bonnet-Delpon. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Benoît Crousse's innovative work in the field of anti-cancer therapy highlights his dedication to advancing medical science. His patents reflect a commitment to finding effective treatments for cancer, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…